FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 128 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $548,000 | -57.3% | 14,558 | -75.1% | 0.00% | +33.3% |
| Q4 2017 | $1,284,000 | -54.3% | 58,501 | -14.8% | 0.00% | -57.1% |
| Q3 2017 | $2,810,000 | +34.1% | 68,636 | -1.4% | 0.01% | +16.7% |
| Q2 2017 | $2,096,000 | +1.0% | 69,643 | +21.3% | 0.01% | 0.0% |
| Q1 2017 | $2,075,000 | -15.4% | 57,409 | +17.3% | 0.01% | -14.3% |
| Q4 2016 | $2,452,000 | -11.3% | 48,938 | -7.1% | 0.01% | -22.2% |
| Q3 2016 | $2,765,000 | +14.9% | 52,677 | -9.5% | 0.01% | +12.5% |
| Q2 2016 | $2,407,000 | – | 58,199 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
| HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
| PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
| BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
| AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
| Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
| Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
| Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |